Biocon Ltd has informed BSE regarding a Press Release dated September 13, 2013 titled "Biocon Partners with CytoSorbents to Market CytoSorb®-A 'First-in-Class' Therapy for Sepsis Management".
Biocon and CytoSorbents Corporation, based in the US, announced today, World Sepsis Day, that they have entered into a strategic partnership with an initial distribution agreement for India and select emerging markets, under which Biocon will have the exclusive commercialization rights for CytoSorb, a novel therapy for the management of sepsis.Source : BSE
Read all announcements in Biocon
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
